Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Neuroene Therapeutics Logo
Neuroene Therapeutics Growth Score
83
CB Rank
49971
Heat Score
65
Neuroene Therapeutics offers novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.
Founded
obfuscation
PrivateGrant Kensington, Maryland, United States1-10 NeuroeneTherapeutics.com
Biotechnology
Therapeutics
Overview

Neuroene Therapeutics
Total Funding
obfuscation
Growth Score
83
Heat Score
65

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score83
-5 pts
in past quarter
Heat Score 65
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Neuroene Therapeutics

CB Rank
49971
Neuroene Therapeutics offers novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.
Founded
obfuscation
PrivateGrant Kensington, Maryland, United States1-10 NeuroeneTherapeutics.com
Biotechnology
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  C. James Chou, Richard Himes, Sherine Chan
About the Company
Neuroene Therapeutics is a startup biotechnology company developing novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.
Contact Email info@neuroenetherapeutics.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Lead Antiseizure Drug (ASD) Candidate
A small molecule drug candidate designed to treat medication-resistant seizures and Parkinson’s disease by targeting mitochondrial dysfunction.
Vitamin K Analogs
A novel class of compounds based on Vitamin K designed to improve mitochondrial function and treat neurological diseases including epilepsy, Parkinson’s disease, and mitochondrial DNA depletion syndrome.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - Neuroene Therapeutics Logo
Grant - Neuroene Therapeutics
1
obfuscation
— Grant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 1

Employee Profiles

News

News and Press

News•Apr 19, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

419

IT Spend

$458.5KThis year, Neuroene Therapeutics is projected to spend $458.5K on IT, according to Aberdeen.

Active Website Tech Count

3Neuroene Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Euro and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is Neuroene Therapeutics's headquarters? Neuroene Therapeutics is located in Kensington, Maryland, United States.Who invested in Neuroene Therapeutics? Neuroene Therapeutics has 4 investors including Johnson & Johnson Innovation and  Small Business Innovation Research.When was the last funding round for Neuroene Therapeutics? Neuroene Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Neuroene Therapeutics's competitors? Alternatives and possible competitors to Neuroene Therapeutics may include Biogen, Stealth BioTherapeutics, and  Khondrion.How much funding has Neuroene Therapeutics raised to date? Neuroene Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|